Skip to main content
Clinical Trials/NCT01186965
NCT01186965
Completed
Not Applicable

Ehealth: Second Life Impacts Diabetes Education & Self-Management

Duke University1 site in 1 country20 target enrollmentJanuary 2011
ConditionsType 2 Diabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type 2 Diabetes
Sponsor
Duke University
Enrollment
20
Locations
1
Primary Endpoint
Process data
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to to develop and evaluate the feasibility, usability, and effect of participation in SLIDES (a virtual diabetes community in Second Life) for providing interactive diabetes education, support, and resources.

Registry
clinicaltrials.gov
Start Date
January 2011
End Date
August 2012
Last Updated
11 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • current Duke Endocrinology patient
  • are between 21 and 75 years old
  • are able to speak and read English
  • are computer literate (have used a computer for at least 6 months)
  • understand how to use the Internet (have accessed the Internet on at least 6 occasions)
  • have access to a computer with a non-dial-up Internet connection in a private location (home)
  • are mentally capable of informed consent
  • are reachable by telephone
  • have no pre-existing medical condition(s) or severe diabetes related complications that would interfere with study participation (i.e., physical activity) or measures (e.g., renal failure, Stage III hypertension, severe orthopedic conditions or joint replacement scheduled within 6 months, paralysis, bleeding disorders, cancer, or receipt of pharmacologic doses of anti-coagulant medications \[warfarin\])
  • are able to travel to Duke University Medical Center (DUMC) for follow-up appointments.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Process data

Time Frame: January 2011 through May 2012

Perceived Usefulness

Time Frame: 3 and 6 months

Perceived Ease of Use

Time Frame: 3 and 6 months

Secondary Outcomes

  • Demographics(baseline)
  • Metabolic Indicators(baseline, 3 months, 6 months)
  • Diabetes knowledge(baseline, 3 months, 6 months)

Study Sites (1)

Loading locations...

Similar Trials